We are live on ! Find out more
PBPH

Portfolio Building Block World Pharma and Biotech Index ETF

11 hedge funds and large institutions have $732M invested in Portfolio Building Block World Pharma and Biotech Index ETF in 2026 Q1 according to their latest regulatory filings, with 11 funds opening new positions, increasing their positions, reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

81,594% more capital invested

Capital invested by funds: $896K → $732M (+$731M)

1,000% more funds holding

Funds holding: 111 (+10)

1,000% more first-time investments, than exits

New positions opened: 11 | Existing positions closed: 1

14.1% more ownership

Funds ownership: 88.78%102.88% (+14%)

Holders
11
Holders Change
+10
Holders Change %
+1,000%
% of All Funds
0.14%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
11
Increased
Reduced
Closed
1
Calls
Puts
Net Calls
Net Calls Change

PBPH Hedge Fund Activity: Q1 2026 in Review

11 of the 8,128 institutional investors tracked by Wall St. Rank reported a position in Portfolio Building Block World Pharma and Biotech Index ETF (PBPH) for Q1 2026, worth a combined $732M — up 81,594% from $896K a quarter earlier.

Buyers outnumbered sellers: 11 funds opened new PBPH positions and 1 closed out — a net gain of 10 holders — while 0 added to existing stakes and 0 trimmed.

The largest buyer was Fisher Asset Management, opening a new position worth an estimated $730M. The largest seller was Citadel Advisors, exiting entirely with an estimated $896K sold.

  • 11 institutional investors held Portfolio Building Block World Pharma and Biotech Index ETF (PBPH) as of Q1 2026, up from 1 in Q4 2025.
  • Funds reported $732M of Portfolio Building Block World Pharma and Biotech Index ETF stock for Q1 2026, up 81,594% quarter-over-quarter.
  • 11 funds opened new Portfolio Building Block World Pharma and Biotech Index ETF positions in Q1 2026 and 1 closed out, a net change of +10 holders.
  • The largest Portfolio Building Block World Pharma and Biotech Index ETF buyer in Q1 2026 was Fisher Asset Management, an estimated $730M added.
  • The largest Portfolio Building Block World Pharma and Biotech Index ETF seller in Q1 2026 was Citadel Advisors, an estimated $896K sold.

Based on aggregated 13F filings for Q1 2026.